NLRP3 and cardiovascular disorder: Many other nutraceuticals have been found to possess therapeutic potential in the treatment of cardiovascular diseases by attenuation of the NLRP3 inflammasome, such as luteolin [57] and dihydromyricetin [56] in atherosclerosis; and colchicine [58], triptolide [59], total flavones [60], umbelliferone [61] in ischemic myocardial disease.